PL2197479T3 - Pirofosforany inzytolu wpływające na zdolność do egzocytozy - Google Patents

Pirofosforany inzytolu wpływające na zdolność do egzocytozy

Info

Publication number
PL2197479T3
PL2197479T3 PL08801778T PL08801778T PL2197479T3 PL 2197479 T3 PL2197479 T3 PL 2197479T3 PL 08801778 T PL08801778 T PL 08801778T PL 08801778 T PL08801778 T PL 08801778T PL 2197479 T3 PL2197479 T3 PL 2197479T3
Authority
PL
Poland
Prior art keywords
exocytotic
capacity
inositol pyrophosphates
pyrophosphates
inositol
Prior art date
Application number
PL08801778T
Other languages
English (en)
Inventor
Per Olof Berggren
Christopher Barker
Original Assignee
Biocrine Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrine Ab filed Critical Biocrine Ab
Publication of PL2197479T3 publication Critical patent/PL2197479T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45Transferases (2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/507Pancreatic cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
PL08801778T 2007-08-31 2008-09-01 Pirofosforany inzytolu wpływające na zdolność do egzocytozy PL2197479T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96944307P 2007-08-31 2007-08-31
EP08801778A EP2197479B1 (en) 2007-08-31 2008-09-01 Inositol pyrophosphates determine exocytotic capacity
PCT/EP2008/007131 WO2009027107A1 (en) 2007-08-31 2008-09-01 Inositol pyrophosphates determine exocytotic capacity

Publications (1)

Publication Number Publication Date
PL2197479T3 true PL2197479T3 (pl) 2011-11-30

Family

ID=40086437

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08801778T PL2197479T3 (pl) 2007-08-31 2008-09-01 Pirofosforany inzytolu wpływające na zdolność do egzocytozy

Country Status (9)

Country Link
US (3) US7855049B2 (pl)
EP (1) EP2197479B1 (pl)
JP (1) JP5491395B2 (pl)
AT (1) ATE512667T1 (pl)
DK (1) DK2197479T3 (pl)
ES (1) ES2368106T3 (pl)
HK (1) HK1144253A1 (pl)
PL (1) PL2197479T3 (pl)
WO (1) WO2009027107A1 (pl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69032284T2 (de) 1989-03-21 1998-10-08 Vical Inc Expression von exogenen polynukleotidsequenzen in wirbeltieren
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
WO2003066087A2 (en) 2002-02-06 2003-08-14 Developgen Aktiengesellschaft Für Entwicklungsbiologische Forschung Kinases involved in the regulation of energy homeostasis
AU2003253880A1 (en) 2002-07-15 2004-02-02 Sugen, Inc. Novel kinases

Also Published As

Publication number Publication date
US7855049B2 (en) 2010-12-21
ES2368106T3 (es) 2011-11-14
WO2009027107A1 (en) 2009-03-05
EP2197479A1 (en) 2010-06-23
JP2010536909A (ja) 2010-12-02
US20090074743A1 (en) 2009-03-19
DK2197479T3 (da) 2011-08-15
JP5491395B2 (ja) 2014-05-14
US20110318325A1 (en) 2011-12-29
EP2197479B1 (en) 2011-06-15
ATE512667T1 (de) 2011-07-15
US20110092577A1 (en) 2011-04-21
HK1144253A1 (en) 2011-02-11

Similar Documents

Publication Publication Date Title
WO2008033408A3 (en) Methods for identifying compounds that modulate cell signaling and methods employing such compounds
IL176142A (en) Processes for preparing montelukast sodium
UA107443C2 (uk) Хімічний спосіб
MX2008001652A (es) Copolimeros de poliamonio-polisiloxano.
TN2010000269A1 (en) 4-phenylpyrane-3,5-diones, 4-phenylthiopyrane-3,5-diones and 2- phenylcyclohexane -1,3,5 - triones as herbicides
GB2477868A (en) Methods and systems for incorporating multiple environmental and genetic risk factors
TN2010000213A1 (en) Wise binding antibodies and epitopes
MY152503A (en) 4-phenyl-pyrane-3, 5-diones, 4-phenyl-thiopyrane-3, 5-diones and cyclohexanetriones as novel herbicides
SG10201408401RA (en) Coiled coil and/or tether containing protein complexes and uses thereof
MX2009012625A (es) Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21.
GB2453058A (en) Kinase antagonists
WO2006015087A3 (en) Thalamic stimulation device
TW200626171A (en) Fixed dosing of HER antibodies
WO2009140039A3 (en) Synthetic antibodies
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
MX2009013410A (es) Biomarcadores para predecir capacidad de respuesta anti-tnf o sin capacidad de respuesta.
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
MY159491A (en) Disubstituted phthalazine hedgehog pathway antagonists
TR201818614T4 (tr) Bir Kromatografi Kolonunun Rejenerasyonuna Yönelik Yöntem
TN2011000166A1 (en) Disubstituted phthalazine hedgehog pathway antagonists
WO2006067311A3 (fr) Inhibiteurs de phosphatases cdc25
WO2009052221A3 (en) Methods for extracting platelets and compositions obtained therefrom
TW200510398A (en) Novel compounds
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения